Latest in Finance

PCI Pharma Services acquires Ajinomoto Althea, makes ground on US and European expansion

PCI's acquisition of US-based sterile fill-finish CDMO Ajinomoto Althea is part of the company's overarching strategy to expand its drug delivery services within the US and Europe

Find out more

Omron and Cognizant to offer IT/OT integration services to pharmaceutical manufacturers

Together, Omron and Cognizant will help manufacturers to integrate IT-OT into their operations and maintenance processes
See more

Roquette completes acquisition of IFF Pharma Solutions

The pharmaceutical excipient specialist will now have access to IFF Pharma's range of biopolymers for the pharmaceutical and biotech industries

Novartis bolsters kidney disease portfolio with Regulus Therapeutics acquisition

Through the acquisition, Novartis will gain access Regulus Therapeutics' oligonucleotide, farabursen, which is designed for the treatment of ADPKD

Samsung Biologics signs $514m manufacturing contract with US-based pharma company

The six year contract manufacturing deal will provide see Samsung Biologics produce pharmaceutical products for an undisclosed, US-based company

AstraZeneca's CEO hints at further US manufacturing and R&D following positive Q1 results

This follows the pharma giant's $3.5bn US investment into manufacturing and R&D announced in November 2024

Amgen pours $900m into US manufacturing capacity with Ohio expansion

The biopharmaceutical company will expand the Ohio facility's operations and construct a second manufacturing plant in Holly Springs, North Carolina

PCI Pharma Serives acquires US-based sterile fill-finish CDMO, Ajinomoto Althea

This acquisition will add antibody-drug conjugate (ADC) manufacturing and US-based sterile fill-finish production capabilities to PCI's portfolio
You need to be a subscriber to read this article.
Click here to find out more.

Tariff hikes call for CPOs to keep reputational issues and costs down

Time for procurement in the pharmaceutical industry to tap into internal expertise

Optimising early-stage drug development with continuous processing

Pharmaceutical innovators face many challenges when developing new products; as such, getting them to market in a timely, safe and cost-effective way is critical. The use of continuous manufacturing technologies can help to overcome some of the most pressing early-stage obstacles

Latest posts in Finance

Novartis to invest $23bn into US manufacturing and R&D capacity

The US investment will involve the construction of seven new manufacturing facilities, as well as a biomedical research innovation hub in San Diego

CDMO PharmaLogic acquires majority stake in Agilera Pharma

By acquiring a majority stake in Agilera, PharmaLogic will bolster its global presence in the promising radiopharmaceutical manufacturing field

Trump's tariffs: an expert's take on pharmaceutical impact, where to go from here

To discuss the potential implications of pharmaceutical tariffs on the industry and how companies should approach these changes, MC spoke with AvaTrade’s Chief Market Analyst, Kate Leaman

CDMO 1Q Health acquires pharmaceutical service provider, VivaCell Biotechnology

This will allow 1Q Health to offer its clients an extended range of pharmaceutical services, including testing, development and drug discovery

Newly established CDMO kicks off operations with Landmark Bio acquisition

Artis BioSolutions, a new CDMO focused on genetic medicines, has acquired Landmark Bio to offer its clients comprehensive, end-to-end advanced therapy manufacturing services

Weight loss drugs fuelling rapid big pharma growth, report reveals

Weight loss and diabetes medications are championing growth in key big pharma players, such as Novo Nordisk and Eli Lilly

Lantheus Holdings completes Evergreen Theragnostics acquisition

By acquiring the radiopharmaceutical specialist, Lantheus Holdings will gain access to Evergreen's radioligand manufacturing capacity, as well as its CDMO division

HAS Healthcare Advanced Synthesis to acquire Cerbios Pharma

Together, the API manufacturers will serve the pharmaceutical industry, offering clients their technical expertise and CDMO services

Trump's pharma tariffs to be introduced "in the near future"

President Donald Trump has announced that he will be introducing tariffs to pharmaceutical imports in the "very near future", though it's unclear if this will begin on April 2 as previously thought

Johnson & Johnson to invest $55bn into US manufacturing, R&D and tech

The company will build three new advanced pharmaceutical manufacturing facilities on top of its biologics manufacturing site in Wilson, North Carolina, which is currently under construction

Delpharm bags $60m Canadian investment to optimise injectable manufacturing facility

The CDMO's Boucherville site will undergo modernisation, ensuring a stable local supply of critical medicines to the Canadian population

Orphan drug sales will continue to rise, 2025 Evaluate report notes

The 2025 Orphan Drug Report notes that orphan drugs will likely make $320bn by 2030, with Johnson & Johnson taking $31.7bn of this

Sponsor content

Gerresheimer: Bormioli Pharma boosts revenues and earnings

Gerresheimer recorded a jump in revenues and earnings due to the first-time consolidation of Bormioli Pharma, which was acquired in 2024

Piramal Pharma Limited announces results for Q3 and 9M FY25

Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) announced its standalone and consolidated results for the Third Quarter (Q3) and Nine Months (9M) ended 31st December...

Vetter strengthens senior management team for growth

Three new managing directors to support global sustainable development

Piramal Pharma Limited reports robust growth in CDMO and sustainability initiatives

US$80 million Lexington expansion to double sterile fill-finish capacity

Piramal Pharma releases Q2 results for FY2025

The company's CDMO business is driving its growth significantly, with a 17% increase YoY

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Ansell acquires Kimberley-Clark's personal protective equipment business

The novel acquisition will bolster Ansell's PPE offerings for customers in the laboratory and cleanroom environments

Medical devices spur growth for ByteSnap Design

Electronics design company employees boosted to 43 as a result of rapid expansion

Cumulus Oncology raises £9m in seed financing

Proceeds from the financing will be used to support Cumulus Oncology’s future growth plans, expand its portfolio and accelerate the development of new cancer treatments...

ADC Therapeutics regains compliance with NYSE continued listing standards

ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs)

SGS joins forces with Agilex Biolabs

This collaboration marks a significant step in strengthening SGS’s global footprint in the bioanalysis services sector

CPHI Barcelona Snapshot: CordenPharma

At CPHI Barcelona, Dr Kevin Robinson talked to Dr Michael Quirmbach, CEO and President of CordenPharma, about the company’s recent activities and what lies ahead